Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

MRD Detection in Myeloma Cells: Comparison between Inexpensive 1-Tube 10 Color Multiparameter Flow Cytometry and Euroflow Multiparameter Flow Cytometry

Kiyoshi Okazuka, MD, Tadao Ishida, MD PhD, Jun Sakamoto, Nobuhiro Tsukada, MD PhD, Kenshi Suzuki, MD PhD

Blood (2019) 134 (Supplement_1): 1832.

https://doi.org/10.1182/blood-2019-123900

Published: 2019

Journal Articles

Changing Trends in the Risk Factors of Secondary Primary Malignancies after Autologous Stem Cell Transplantation for Multiple Myeloma before and after the Introduction of Proteasome Inhibitors/Immunomodulatory Agents

Hiroyuki Takamatsu, MD PhD, Shohei Mizuno, MD PhD, Tsutomu Takahashi, MD PhD, Shin-Ichi Fuchida, MD PhD, Ichiro Hanamura, MD PhD, Fumihiko Nakamura, MD PhD, Takehiko Mori, MD PhD, Yuta Katayama, MD PhD, Noriko Doki, MD PhD, Nobuhiro Tsukada, MD PhD, Tatsuo Ichinohe, Yoshinobu Kanda, MD PhD, Yoshiko Atsuta, MD PhD, Kazutaka Sunami, MD PhD

Blood (2019) 134 (Supplement_1): 4358.

https://doi.org/10.1182/blood-2019-123607

Published: 2019

Journal Articles

10 Years History of Cost-Effectiveness for 209 Newly Diagnosed Multiple Myeloma Patients at a Single-Institute in Japan

Kenshi Suzuki, MD PhD, Tomofumi Yamamoto, Masahiro Ikeda, MD, Tomomi Takei, MD, Nobuhiro Tsukada, MD PhD, Tadao Ishida, MD PhD, Arimi Ueda, Daiju Ichikawa, PhD, Maiko Matsushita, MD PhD, Yutaka Hattori, MD PhD

Blood (2016) 128 (22): 5620.

https://doi.org/10.1182/blood.V128.22.5620.5620

Published: 2016

Journal Articles

Difference of Treatment Outcomes in AL Amyloidosis and Multiple Myeloma with / without Translocation (11;14)

Kenshi Suzuki, Miho Kasuga, trainee, Kanji Miyazaki, MD, Sohsuke Meshitsuka, MD, Yu ABE, MD, Yumiko Yoshiki, MD PhD, Nobuhiro Tsukada, MD PhD

Blood (2015) 126 (23): 4224.

https://doi.org/10.1182/blood.V126.23.4224.4224

Published: 2015

Journal Articles

The Impact of Donor Age on Outcome after Unrelated Bone Marrow Transplantation: Comparison with Unrelated Cord Blood Transplantation

Sachiko Seo, MD PhD, Junya Kanda, Yoshiko Atsuta, MDPhD, Naoyuki Uchida, Kazuteru Ohashi, MD FACP, Takahiro Fukuda, MD, Satoshi Takahashi, MD,PhD, Yukiyasu Ozawa, MD, Makoto Onizuka, MD PhD, Minoko Takanashi, MD PhD, Nobuhiro Tsukada, MD PhD, Shunichi Kato, MD PhD, Fumihiko Kimura, MD, Yoshinobu Kanda, MD PhD, Koichi Miyamura, MD PhD

Blood (2015) 126 (23): 154.

https://doi.org/10.1182/blood.V126.23.154.154

Published: 2015

Journal Articles

Comparison of Outcomes of Unrelated BM and CB Transplants in Young Adult Leukemia Patients. Updated Results of Japanese Registration Study

Seitaro Terakura, MD PhD, Yoshiko Atsuta, MD, Nobuhiro Tsukada, MD PhD, Takeshi Kobayashi, MD, Masatsugu Tanaka, MD, Junya Kanda, Kazuteru Ohashi, MD PhD, Takahiro Fukuda, MD, Naoyuki Uchida, MD PhD, Takahashi Satoshi, MD, Tokiko Nagamura-Inoue, Yasuo Morishima, MD, Koichi Miyamura

Blood (2014) 124 (21): 45.

https://doi.org/10.1182/blood.V124.21.45.45

Published: 2014

Journal Articles

Impact Of Novel Agents To The Additional-Chromosomal Abnormalities In Patients With Multiple Myeloma

Kenshi Suzuki, MD, PhD, Yu Abe, Kanji Miyazaki, Rieko Sekine, MD, PhD, Nobuhiro Tsukada, MD, PhD, Yutaka Hattori, MD, PhD, Airi Hamano, Sumito Shingaki

Blood (2013) 122 (21): 3225.

https://doi.org/10.1182/blood.V122.21.3225.3225

Published: 2013

Journal Articles

Discovery Research On the Effects of Continuous Administration of Bortezomib Maintenance Therapy to Treat Patients with Relapsed and Refractory Multiple Myeloma - Analysis of Background Factors That Affect the Continuity of Therapy-

Kenshi Suzuki, MD, PhD, Nobuhiro Tsukada, MD, PhD, Yu Abe, MD, Rieko Sekine, MD, PhD, Yasunori Nakagawa, MD, PhD

Blood (2012) 120 (21): 1866.

https://doi.org/10.1182/blood.V120.21.1866.1866

Published: 2012

Journal Articles

Micafungin Is Extremely Effective Against Fungal Infections Complicating Hematological Malignancies: Report of a Multicenter Study by N-FISH (Niigata Fungal Infection Study Group in Hematology).

Sadao Aoki, MD, PhD, Jun Takizawa, MD, PhD, Yoshinobu Seki, MD, Kazue Takai, MD, Koji Nikkuni, MD, PhD, Souichi Maruyama, MD, PhD, Nobuhiko Nomoto, MD, PhD, Nobuhiro Tsukada, MD, PhD, Yoshifusa Aizawa, MD

Blood (2005) 106 (11): 5350.

https://doi.org/10.1182/blood.V106.11.5350.5350

Published: 2005

Journal Articles

The Useful Individualized Assessment of Immunosuppressive Therapy with Cyclosporine A (CsA) after Allogeneic Stem Cell Transplantation by Simultaneous Analyses of Cytokine Production among CD4+ T Cells and Blood CsA Levels.

Nobuhiro Tsukada, MD, PhD, Tatsuo Furukawa, MD, PhD, Hiromi Ito, Noriko Izumi, MD, Akihito Momoi, MD, Kiyoshi Okazuka, MD, Keiichiro Honma, MD, Masayoshi Masuko, MD, PhD, Shigeo Hashimoto, MD, PhD, Sadao Aoki, MD, PhD, Yoshifusa Aizawa, MD, PhD

Blood (2004) 104 (11): 5076.

https://doi.org/10.1182/blood.V104.11.5076.5076

Published: 2004

Journal Articles

High-Dose Bi-Weekly THP-COP Induction Treatment Followed by High-Dose Therapy with Autologous Peripheral Blood Stem Cell Transplantation for Advanced-Stage Follicular Lymphoma as First-Line Therapy.

Sadao Aoki, MD, PhD, Jun Takizawa, MD, PhD, Masutaka Higashimura, MD, Akihito Momoi, MD, Nobuhiro Tsukada, MD, PhD, Koji Nikkuni, MD, PhD, Nobuhiko Nomoto, MD, PhD, Yoshifusa Aizawa, MD

Blood (2004) 104 (11): 5207.

https://doi.org/10.1182/blood.V104.11.5207.5207

Published: 2004

Journal Articles

Nurselike Cells in Chronic Lymphocytic Leukemia (CLL) Express Both BAFF and APRIL that Protect CLL B Cells from Spontaneous Apoptosis by Paracrine Manner.

Mitsufumi Nishio, MD, PhD, Nobuhiro Tsukada, MD, PhD, Junko Ohata, MD, PhD, Nathan J. Zvaifler, MD, Thomas J. Kipps, MD, PhD

Blood (2004) 104 (11): 965.

https://doi.org/10.1182/blood.V104.11.965.965

Published: 2004

Journal Articles

BAFF Support Survival of Chronic Lymphocytic Leukemia B Cells by a Pathway Independent of Stromal Derived Factor-1α.

Mitsufumi Nishio, MD, PhD, Nobuhiro Tsukada, MD, PhD, Shinichi Kitada, MD, PhD, Junko Ohata, MD, PhD, Nathan J. Zvaifler, MD, John C. Reed, MD, PhD, Thomas J. Kipps, MD, PhD

Blood (2004) 104 (11): 1908.

https://doi.org/10.1182/blood.V104.11.1908.1908

Published: 2004

NARROW

MRD Detection in Myeloma Cells: Comparison between Inexpensive 1-Tube 10 Color Multiparameter Flow Cytometry and Euroflow Multiparameter Flow Cytometry

Changing Trends in the Risk Factors of Secondary Primary Malignancies after Autologous Stem Cell Transplantation for Multiple Myeloma before and after the Introduction of Proteasome Inhibitors/Immunomodulatory Agents

10 Years History of Cost-Effectiveness for 209 Newly Diagnosed Multiple Myeloma Patients at a Single-Institute in Japan

Difference of Treatment Outcomes in AL Amyloidosis and Multiple Myeloma with / without Translocation (11;14)

The Impact of Donor Age on Outcome after Unrelated Bone Marrow Transplantation: Comparison with Unrelated Cord Blood Transplantation

Comparison of Outcomes of Unrelated BM and CB Transplants in Young Adult Leukemia Patients. Updated Results of Japanese Registration Study

Impact Of Novel Agents To The Additional-Chromosomal Abnormalities In Patients With Multiple Myeloma

Discovery Research On the Effects of Continuous Administration of Bortezomib Maintenance Therapy to Treat Patients with Relapsed and Refractory Multiple Myeloma - Analysis of Background Factors That Affect the Continuity of Therapy-

Micafungin Is Extremely Effective Against Fungal Infections Complicating Hematological Malignancies: Report of a Multicenter Study by N-FISH (Niigata Fungal Infection Study Group in Hematology).

The Useful Individualized Assessment of Immunosuppressive Therapy with Cyclosporine A (CsA) after Allogeneic Stem Cell Transplantation by Simultaneous Analyses of Cytokine Production among CD4+ T Cells and Blood CsA Levels.

High-Dose Bi-Weekly THP-COP Induction Treatment Followed by High-Dose Therapy with Autologous Peripheral Blood Stem Cell Transplantation for Advanced-Stage Follicular Lymphoma as First-Line Therapy.

Nurselike Cells in Chronic Lymphocytic Leukemia (CLL) Express Both BAFF and APRIL that Protect CLL B Cells from Spontaneous Apoptosis by Paracrine Manner.

BAFF Support Survival of Chronic Lymphocytic Leukemia B Cells by a Pathway Independent of Stromal Derived Factor-1α.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only